These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7153621)

  • 1. [Experimental studies on specific active immunotherapy using immune responses of irradiated tumor tissue. 4. Effects of a combined use of a non-specific immunopotentiator, OK-432].
    Imanaka K; Ogawa Y; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1299-304. PubMed ID: 7153621
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies on specific active immunotherapy using immune response of irradiated tumor tissues. 5. A combined effect of the immune response of cryopreserved tissue and OK-432].
    Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1305-10. PubMed ID: 7153622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of an immunomodifier on radiation-induced antitumor immunity following local irradiation of the tumor--1. OK-432].
    Mukae S; Norimura T; Tsuchiya T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jun; 47(6):838-44. PubMed ID: 3684525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 3. Effect of the cryopreserved immune reaction].
    Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1293-8. PubMed ID: 7153620
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adoptive immunotherapy of murine tumors using cultured syngeneic tumor-bearer-spleen cells. II: Therapeutic effect of cultured lymphocytes against malignant ascites and its augmentation by the streptococcal preparation, OK 432].
    Kan N; Inamoto T; Hori T; Nio Y; Tsuchitani T; Kodama H; Tobe T; Ohgaki K
    Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):784-96. PubMed ID: 3877129
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of non-A, non-B hepatitis with immunopotentiator OK-432].
    Shimada Y; Hirakawa H; Fukumoto S; Nagaoka S
    Nihon Rinsho; 1988 Dec; 46(12):2689-702. PubMed ID: 3149343
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy].
    Nishida Y; Sakakibara K; Kano T; Ohta M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1017-25. PubMed ID: 3746020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. I. Experimental study using a rat model of malignant ascites].
    Umemoto T; Saji S; Minatsu H; Kunii Y; Goshima H; Tachibana S; Takao H; Sakata K
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1229-35. PubMed ID: 3230342
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immune responses and clinical effects of OK-432 immunotherapy in lung neoplasms].
    Watanabe H; Komori Y; Yamada T; Iwa T
    Nihon Kyobu Geka Gakkai Zasshi; 1979 Apr; 27(4):451-8. PubMed ID: 469305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental study on active specific immunotherapy utilizing the immune reaction of low-dose irradiated tumor tissue. 9. Effect of the mitomycin C-treated, cryopreserved immune reaction combined with biological response modifier, OK-432].
    Ogawa Y; Maeda T; Yoshida S; Yamamoto Y; Morita M; Ogawa Y; Imanaka K; Gose K; Imajo Y; Kimura S
    Nihon Gan Chiryo Gakkai Shi; 1983 Jun; 18(4):946-50. PubMed ID: 6413627
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental study on the effectiveness of BRM in radiation therapy--OK-432 and cyclophosphamide].
    Norimura T; Kunugita N; Dohi S; Mukae S; Tsuchiya T
    Gan No Rinsho; 1988 Oct; 34(13):1811-5. PubMed ID: 3199515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
    Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental study on the antitumor activity of regional lymph nodes during immunotherapy].
    Kawata H
    Nihon Geka Gakkai Zasshi; 1984 Nov; 85(11):1479-89. PubMed ID: 6521727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between anti-tumor effect and delayed hypersensitivity induced by topically applied OK-432 with histological findings].
    Kokunai I; Mori T; Yayoi E; Matuura N; Kosaki G
    Nihon Geka Gakkai Zasshi; 1985 Mar; 86(3):258-65. PubMed ID: 3982380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of the synergy of microwave coagulation and streptococcal preparation (OK-432) in experimental tumors in relation to interleukin 2 producing activity].
    Yamaue H; Katsumi M; Tabuse K; Tabuse Y; Egawa H; Noguchi H; Nagai Y; Kobayashi Y; Mori K
    Nihon Geka Hokan; 1986 Sep; 55(5):689-99. PubMed ID: 3495246
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy of local administration of OK-432 and radiation on a murine fibrosarcoma (NFSa)--combination effect and histological examination].
    Mukai M; Ando K; Koike S; Ishikawa T; Ryu M; Nagashima T; Nagao K; Isono K
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):556-62. PubMed ID: 3954378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of OK-432 on modifying a spontaneous lung metastasis from murine fibrosarcomas].
    Ito H; Yamada S; Nishiguchi I; Shigematsu N; Nakayama T; Kuribayashi T; Hashimoto S
    Gan No Rinsho; 1990 Aug; 36(9):993-7. PubMed ID: 2381054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of concomitant use of non-specific immunopotentiator on 172 cases of primary lung cancer (stage III, IV) treated with radiation combined with chemotherapy (author's transl)].
    Ogawa Y; Kimura S; Imajo Y; Hamada F; Miyaji C; Imanaka K; Takashima H; Ohbayashi K; Takada Y
    Rinsho Hoshasen; 1982 Apr; 27(4):451-4. PubMed ID: 7109272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.